SCHEMBL1704587

SCHEMBL1704587

CCCCCCCCCC(CC)C(=O)O

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 4/20 0.83
MAPK1 P28482 1/20 0.83
GRIK1 P39086 2/20 0.63
GRIK2 Q13002 2/20 0.63
SLC1A2 P43004 2/20 0.60
SLC1A1 P43005 2/20 0.60
GPR84 Q9NQS5 5/20 0.59
FFAR1 O14842 1/20 0.59
MAPT P10636 1/20 0.57
LCK P06239 1/20 0.57
PPARD Q03181 1/20 0.57
ZDHHC20 Q5W0Z9 1/20 0.57
ZDHHC2 Q9UIJ5 1/20 0.57
CA1 P00915 1/20 0.54
ACE2 Q9BYF1 1/20 0.53
CHRM1 P11229 1/20 0.52
AKR1A1 P14550 1/20 0.52
CHRM3 P20309 1/20 0.52
HTR2A P28223 1/20 0.52
HTR2C P28335 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL167273 1.00 CA2 (0.83) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL10788879 1.00 CA2 (0.83) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL687840 1.00 CA2 (0.83) CA2MAPK1GRIK1GRIK2SLC1A2
Hexane SCHEMBL4788148 1.00 CA2 (0.83) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL249553 1.00 CA2 (0.83) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL2492860 1.00 CA2 (0.83) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL17329112 1.00 CA2 (0.83) CA2MAPK1GRIK1GRIK2SLC1A2
Hexane SCHEMBL18237384 1.00 CA2 (0.83) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL3003696 1.00 CA2 (0.83) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL1645242 1.00 CA2 (0.83) CA2MAPK1GRIK1GRIK2SLC1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 221 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3648613-B1 COMPOSITIONS AND METHODS FOR A UNIVERSAL CLINICAL TEST FOR OLFACTORY DYSFUNCTION UNIV ROCKEFELLER (US) 2025-09-24 EP claimed
CN-111574537-B Synthesis method of tert-butyl-8-oxa-3,11-diazaspiro [5.6] dodecane-3-formylate 成都药明康德新药开发有限公司 2022-11-15 CN claimed
CN-112625246-A Terminally functionalized polymers and related methods 株式会社普利司通 2021-04-09 CN claimed
CN-111574537-A Synthesis method of tert-butyl-8-oxa-3, 11-diazaspiro [5.6] dodecane-3-formylate 成都药明康德新药开发有限公司 2020-08-25 CN claimed
US-10011554-B2 Alpha-branched alkenoic acids and the use of alpha-branched alkanoic and alkenoic acids as a fragrance Givaudan, S.A. (CH) 2018-07-03 US claimed
CN-107428940-A Terminally functionalized polymers and related methods 株式会社普利司通 2017-12-01 CN claimed
US-20170327452-A1 ALPHA-BRANCHED ALKENOIC ACIDS AND THE USE OF ALPHA-BRANCHED ALKANOIC AND ALKENOIC ACIDS AS A FRAGRANCE GIVAUDAN S.A. (CH) 2017-11-16 US claimed
US-9745245-B2 Alpha-branched alkenoic acids and the use of alpha-branched alkanoic and alkenoic acids as a fragrance GIVAUDAN S.A. (CH) 2017-08-29 US claimed
EP-2872538-A1 ZIEGLER-NATTA CATALYST SYSTEMS COMPRISING A 1,2-PHENYLENEDIOATE AS INTERNAL DONOR AND PROCESS FOR PREPARING THE SAME Indian Oil Corporation Ltd (IN) 2015-05-20 EP claimed
WO-2014013401-A1 ZIEGLER-NATTA CATALYST SYSTEMS COMPRISING A 1,2-PHENYLENEDIOATE AS INTERNAL DONOR AND PROCESS FOR PREPARING THE SAME INDIAN OIL CORPORATION LIMITED (IN) 2014-01-23 WO claimed
US-20080015278-A1 Metal-Containing Compositions and Method of Making Same PRYOG, LLC 2008-01-17 US claimed
EP-1697386-B1 ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES GEN ELECTRIC (US) 2007-10-10 EP claimed
WO-2007070092-A2 METAL-CONTAINING COMPOSITIONS AND METHOD OF MAKING SAME PRYOG, LLC (US) 2007-06-21 WO claimed
EP-1328161-B1 AMBIENT STABLE BEVERAGE UNILEVER PLC (GB) 2007-04-18 EP claimed
EP-1282368-B1 AMBIENT STABLE BEVERAGE UNILEVER PLC (GB) 2005-07-27 EP claimed
US-5736503-A High sudsing detergent compositions with specially selected soaps THE PROCTER & GAMBLE COMPANY (US) 1998-04-07 US claimed
EP-0670885-B1 HIGH SUDSING DETERGENT COMPOSITIONS WITH SPECIALLY SELECTED SOAPS PROCTER & GAMBLE (US) 1997-08-20 EP claimed
CN-1090887-A The high-sudsers composition that contains specially selected soap PROCTER & GAMBLE (US) 1994-08-17 CN claimed
WO-1994012608-A1 HIGH SUDSING DETERGENT COMPOSITIONS WITH SPECIALLY SELECTED SOAPS THE PROCTER & GAMBLE COMPANY (US) 1994-06-09 WO claimed
US-3932476-A REACTION OF A FATTY ACID ESTER WITH AMMONIA OR AN AMINE ETHYL CORPORATION (US) 1976-01-13 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10011554-B2 Alpha-branched alkenoic acids and the use of alpha-branched alkanoic and alkenoic acids as a fragrance FASN, ELOVL1, ACOX1 CA2 2247/4885MAPK1 2426/4885GRIK1 1038/4885
US-20170327452-A1 ALPHA-BRANCHED ALKENOIC ACIDS AND THE USE OF ALPHA-BRANCHED ALKANOIC AND ALKENOIC ACIDS AS A FRAGRANCE FASN, ELOVL1, ACOX1 CA2 2247/4885MAPK1 2426/4885GRIK1 1038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.